Biomarkers of glomerular dysfunction in pre-eclampsia – A systematic review

Robert N. Kerley1, Cathal McCarthy1
1Irish Centre for Fetal and Neonatal Translational Research (INFANT), Cork University Maternity Hospital, Cork, Ireland

Tài liệu tham khảo

Kenny, 2014, Early pregnancy prediction of preeclampsia in nulliparous women, combining clinical risk and biomarkers: the Screening for Pregnancy Endpoints (SCOPE) international cohort study, Hypertension, 64, 644, 10.1161/HYPERTENSIONAHA.114.03578

Craici, 2013, Podocyturia predates proteinuria and clinical features of preeclampsia: longitudinal prospective study, Hypertension, 61, 1289, 10.1161/HYPERTENSIONAHA.113.01115

National Collaborating Centre for Ws, Children's H, 2010

Papanna, 2008, Protein/creatinine ratio in preeclampsia: a systematic review, Obstet Gynecol., 112, 135, 10.1097/AOG.0b013e3181778cfc

Sugimoto, 2003, Neutralization of circulating vascular endothelial growth factor (VEGF) by anti-VEGF antibodies and soluble VEGF receptor 1 (sFlt-1) induces proteinuria, J. Biol. Chem., 278, 12605, 10.1074/jbc.C300012200

Kelder, 2012, Quantitative polymerase chain reaction-based analysis of podocyturia is a feasible diagnostic tool in preeclampsia, Hypertension, 60, 1538, 10.1161/HYPERTENSIONAHA.112.201681

Conde-Agudelo, 2004, World Health Organization systematic review of screening tests for preeclampsia, Obstet Gynecol., 104, 1367, 10.1097/01.AOG.0000147599.47713.5d